Michelle Collins
Family · Farmington Hills, MINPI 1235235813
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 450 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,988, 7.2 times the $413 reported in 2021. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 450 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Axsome Therapeutics, Inc.$895
- Teva Pharmaceuticals USA, Inc.$890
- Johnson & Johnson$704
- AbbVie$700
- Otsuka America Pharmaceutical, Inc.$592
- plus $4K from 14 others
What the payments were for
- Food & beverage$8,74898%
- Education$1762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 110 | $1,591 |
| Axsome Therapeutics, Inc. | 36 | $895 |
| Teva Pharmaceuticals USA, Inc. | 46 | $890 |
| Johnson & Johnson | 21 | $704 |
| AbbVie | 24 | $700 |
| Otsuka America Pharmaceutical, Inc. | 30 | $592 |
| Neurocrine Biosciences, Inc. | 18 | $556 |
| Corium, LLC | 34 | $505 |
| Alkermes, Inc. | 27 | $473 |
| Supernus Pharmaceuticals, Inc. | 15 | $432 |
| Sunovion Pharmaceuticals Inc. | 20 | $349 |
| Lundbeck LLC | 20 | $344 |
| Ironshore Pharmaceuticals Inc. | 16 | $318 |
| E.r. Squibb & Sons, L.L.C. | 16 | $260 |
| Collegium Pharmaceutical, Inc. | 6 | $124 |
| Luye Pharma (USA) Ltd. | 5 | $82 |
| Almatica Pharma LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Indivior Inc. | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$358
- INVEGA SUSTENNA$324
- INGREZZA$243
- QELBREE$202
- Auvelity$121
- Austedo XR$114
- CAPLYTA$102
How this compares
$8,924 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 27 | $1,712 |
| Trazodone Hcl | 29 | $201 |
| Escitalopram Oxalate | 21 | $177 |
| Oxcarbazepine | 12 | $157 |
| Memantine Hcl | 12 | $157 |
| Gabapentin | 11 | $61 |
| Donepezil Hcl | 12 | $43 |
| Risperidone | 15 | $31 |
Paid to pharmacies, not to this prescriber.
Other family in Farmington Hills
- Sarah JohnsonFarmington Hills$119K
- Reba IssacFarmington Hills$17K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.